These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7639673)

  • 1. A topical carbonic anhydrase inhibitor finally arrives.
    Palmberg P
    Arch Ophthalmol; 1995 Aug; 113(8):985-6. PubMed ID: 7639673
    [No Abstract]   [Full Text] [Related]  

  • 2. The hypotensive efficacy of dorzolamide HCL-timolol maleate 0.50% vs concomitant use of the two drugs.
    Durante A; Aurilia P; Guarnaccia G; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):46. PubMed ID: 11235533
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical carbonic anhydrase inhibitors.
    Kass MA
    Am J Ophthalmol; 1989 Mar; 107(3):280-2. PubMed ID: 2923154
    [No Abstract]   [Full Text] [Related]  

  • 4. MK-927: a topically effective carbonic anhydrase inhibitor in patients.
    Bron AM; Lippa EA; Hofmann HM; Feicht BI; Royer JG; Brunner-Ferber FL; Panebianco DL; Von Denffer HA
    Arch Ophthalmol; 1989 Aug; 107(8):1143-6. PubMed ID: 2667509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Glaucoma Prevention Study.
    Quigley HA
    Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the efficacy on intraocular pressure and retinal blood flow of a beta-blocker (timolol maleate) against the fixed association of a topical carbonic anhydrase (dorzolamide) and a beta-blocker (timolol maleate).
    Brogliatti B; Rolle T; Vizzeri GM; Cipullo D
    Acta Ophthalmol Scand Suppl; 2000; (232):47-9. PubMed ID: 11235534
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927.
    Lippa EA; Aasved H; Airaksinen PJ; Alm A; Bertelsen T; Calissendorff B; Dithmer O; Eriksson LO; Gustad L; Høvding G
    Arch Ophthalmol; 1991 Jan; 109(1):46-9. PubMed ID: 1987947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
    D'Andrea A; D'Andrea D; Ferreri G
    Acta Ophthalmol Scand Suppl; 1998; (227):36-8. PubMed ID: 9972339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor.
    Lippa EA; Carlson LE; Ehinger B; Eriksson LO; Finnström K; Holmin C; Nilsson SE; Nyman K; Raitta C; Ringvold A
    Arch Ophthalmol; 1992 Apr; 110(4):495-9. PubMed ID: 1562255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
    Pfeiffer N; Hennekes R; Lippa EA; Grehn F; Garus H; Brunner-Ferber FL
    Br J Ophthalmol; 1990 Jul; 74(7):405-8. PubMed ID: 2198931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E; Tipping R; Vogel R
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of dorzolamide vs. pilocarpine for primary open-angle glaucoma.
    Rocchi A; Tingey D
    Can J Ophthalmol; 1997 Oct; 32(6):414-8. PubMed ID: 9363347
    [No Abstract]   [Full Text] [Related]  

  • 16. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].
    Herkel U; Pfeiffer N
    Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
    Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
    Manni GL; Centofanti M; Napoli D; Parisi V; Bucci MG
    Acta Ophthalmol Scand Suppl; 1997; (224):22-3. PubMed ID: 9589714
    [No Abstract]   [Full Text] [Related]  

  • 20. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.